Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

Josep Tabernero, Enrico Mini, Fabien Subtil, +14

The Lancet Oncology

Surgical OncologyGastrointestinal OncologyMedicineRandomised Phase 3Pathology +6

Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial

R Zittoun, Stefan Suciu, Maggie Watson, +9

Bone Marrow Transplantation

Hematological MalignancyQuality Of LifeTransplantationMarrow TransplantationEortc-gimema Aml 8A +8

Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.

R Zittoun, Stefan Suciu, Franco Mandelli, +9

Journal of Clinical Oncology

Pentostatin in Refractory Chronic Lymphocytic Leukemia: A Phase II Trial of the European Organization for Research and Treatment of Cancer

Anthony D. Ho, J. Thaler, P Stryckmans, +13

JNCI Journal of the National Cancer Institute

Pentostatin in Prolymphocytic Leukemia: Phase II Trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group

H. Döhner, Anthony D. Ho, J. Thaler, +11

JNCI Journal of the National Cancer Institute

Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups.

S. Keating, Stefan Suciu, T.J.M. de Witte, +16

PubMed

Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX

Jean‐François Emile, Catherine Julié, Karine Le Malicot, +330

European Journal of Cancer

Prognostic BiomarkersGastrointestinal OncologyMedicineImmunologyColorectal Cancer +7

The Safety Profile of Low-dose Cladribine in Refractory Rheumatoid Arthritis

Michael Schirmer, Erich Mur, Karl Pfeiffer, +2

Scandinavian Journal of Rheumatology

An aggressive subtype of B‐CLL is characterized by strong CD44 expression and lack of CD11c

Wolfgang Eisterer, Wolfgang Hilbe, Reinhard Stauder, +3

British Journal of Haematology

Long‐term follow‐up of patients with hairy cell leukaemia treated with pentostatin: lymphocyte subpopulations and residual bone marrow infiltration

J. Thaler, Kurt Grünewald, Claus Gattringer, +7

British Journal of Haematology